The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine
Abstract
Conspectus Over the past few decades, cancer nanomedicine has been under intensive development for applications in drug delivery, cancer therapy, and molecular imaging. However, there exist a series of complex biological barriers in the path of a nanomedicine from the site of administration to the site of action. These barriers considerably prevent a nanomedicine from reaching its targets in a sufficient concentration and thus severely limit its therapeutic benefits. According to the delivery process, these biological delivery barriers can be briefly summarized in the following order: blood circulation, tumor accumulation, tumor penetration, cellular internalization, and intracellular drug release. The therapeutic effect of a nanomedicine is strongly determined by its ability to overcome these barriers. However, advances in cancer biology have revealed that each barrier has its own distinct microenvironment, which imposes different requirements on the optimal design of nanocarriers, thus further complicating the delivery process. For example, the pH of blood is neutral, while the tumor extracellular environment features an acidic pH (pH e ≈ 6.5–7.0) and the endosome and lysosome are more acidic (pH 5.5–4.5). The nanoparticles (NPs) should be able to change their properties to adapt to each individual environment for robust and effective delivery. This demand promotes the design and development of smart delivery carriers that can respond to endogenous and exogenous stimuli. It is well-documented that tumors develop acidic extracellular microenvironments with pH ≈ 6.5–7.0 due to their abnormal metabolism in comparison with normal tissues. This provides a unique tool for designing smart NP drug delivery systems. Our studies have revealed that the NPs’ physiochemical properties, such as particle size and surface charge, have profound effects on their systemic transport in the body. In different delivery stages, the NPs should possess different sizes or surface charges for optimal performance. We developed a class of stimuli-responsive NPs by incorporating tumor-acidity-cleavable maleic acid amide (TACMAA) as a design feature. TACMAA is produced by the facile reaction of an amino group with 2,3-dimethylmaleic anhydride (DMMA) and its derivatives and can be cleaved under tumor acidity. By virtue of such characteristics, NPs containing TACMAA enable size or surface charge switching at tumor sites so that they can overcome those delivery barriers for improved drug delivery and cancer therapy. In this Account, we systemically review the development and evolution of TACMAA-based delivery systems and elaborate how TACMAA helps the innovation and design of intelligent nanocarriers for overcoming the delivery barriers. In particular, our Account focuses on five parts: TACMAA chemistry, tumor-acidity-triggered charge reversal, tumor-acidity-triggered shell detachment, tumor-acidity-triggered size transition, and tumor-acidity-triggered ligand reactivation. We provide detailed information on how tumor-acidity-triggered property changes correlate with the ability of NPs to overcome delivery barriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Dysregulated pH: a perfect storm for cancer progression
Webb, B. A., Chimenti, M., Jacobson, M. P., & Barber, D. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3110 · Cited by 2,237
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
Self-citationCho, E. C., Xie, J., Wurm, P. A., & Xia, Y. (2009) · Nano Letters · doi:10.1021/nl803487r · Cited by 819
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Self-citationFeng, T., Ai, X., An, G., Yang, P., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b00043 · Cited by 650
Zhou, K., Wang, Y., Huang, X., Luby‐Phelps, K., Sumer, B. D., & Gao, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100884 · Cited by 573
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
Self-citationDu, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907210 · Cited by 520
Self-citationSequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors
Chen, J., Ding, J., Wang, Y., Cheng, J., Ji, S., Zhuang, X., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201701170 · Cited by 420
A Protein Nanocarrier from Charge-Conversion Polymer in Response to Endosomal pH
Lee, Y., Fukushima, S., Bae, Y., Hiki, S., Ishii, T., & Kataoka, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071090b · Cited by 404
Targeted Charge‐Reversal Nanoparticles for Nuclear Drug Delivery
Xu, P., Van Kirk, E. A., Zhan, Y., Murdoch, W. J., Radosz, M., & Shen, Y. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605254 · Cited by 370
Wang, C., Cheng, L., Liu, Y., Wang, X., Ma, X., Deng, Z., Li, Y., & Liu, Z. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201202992 · Cited by 355
Lee, Y., Ishii, T., Cabral, H., Kim, H. J., Seo, J., Nishiyama, N., Oshima, H., Osada, K., & Kataoka, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900064 · Cited by 351
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery
Sun, C.-Y., Shen, S., Xu, C.-F., Li, H.-J., Liu, Y., Cao, Z.-T., Yang, X.-Z., Xia, J.-X., & Wang, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09602 · Cited by 343
Self-citationSheddable Ternary Nanoparticles for Tumor Acidity-Targeted siRNA Delivery
Yang, X.-Z., Du, J.-Z., Dou, S., Mao, C.-Q., Long, H.-Y., & Wang, J. (2012) · ACS Nano · doi:10.1021/nn204240b · Cited by 284
Self-citationMultistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics
Godin, B., Tasciotti, E., Liu, X., Serda, R. E., & Ferrari, M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200077p · Cited by 211
A transistor-like pH nanoprobe for tumour detection and image-guided surgery
Zhao, T., Huang, G., Li, Y., Yang, S., Ramezani, S., Lin, Z., Wang, Y., Ma, X., Zeng, Z., Luo, M., et al. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0006 · Cited by 206
Du, J.-Z., Mao, C.-Q., Yuan, Y.-Y., Yang, X.-Z., & Wang, J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.002 · Cited by 202
Self-citationLee, Y., Ishii, T., Kim, H. J., Nishiyama, N., Hayakawa, Y., Itaka, K., & Kataoka, K. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200905264 · Cited by 198
Shen, S., Li, H.-J., Chen, K.-G., Wang, Y.-C., Yang, X.-Z., Lian, Z.-X., Du, J.-Z., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01193 · Cited by 186
Self-citationFacile Generation of Tumor‐pH‐Labile Linkage‐Bridged Block Copolymers for Chemotherapeutic Delivery
Sun, C., Liu, Y., Du, J., Cao, Z., Xu, C., & Wang, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509507 · Cited by 165
Self-citationDual-Responsive Polymer Micelles for Target-Cell-Specific Anticancer Drug Delivery
Guo, X., Shi, C., Yang, G., Wang, J., Cai, Z., & Zhou, S. (2014) · Chemistry of Materials · doi:10.1021/cm5012718 · Cited by 153
Self-citationRational Design of Polyion Complex Nanoparticles to Overcome Cisplatin Resistance in Cancer Therapy
Yang, X., Du, X., Liu, Y., Zhu, Y., Liu, Y., Li, Y., & Wang, J. (2013) · Advanced Materials · doi:10.1002/adma.201303360 · Cited by 144
Self-citationLi, L., Sun, W. Y., Zhong, J., Yang, Q., Zhu, X. D., Zhou, Z., Zhang, Z., & Huang, Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501248 · Cited by 135
Nanoengineered Templated Polymer Particles: Navigating the Biological Realm
Cui, J., Richardson, J. J., Björnmalm, M., Faria, M., & Caruso, F. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00088 · Cited by 131
Li, L., Yang, Q., Zhou, Z., Zhong, J., & Huang, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.027 · Cited by 129
pH-Sensitive siRNA Nanovector for Targeted Gene Silencing and Cytotoxic Effect in Cancer Cells
Mok, H., Omid Veiseh, A., Fang, C., Kievit, F. M., Wang, F. Y., Park, J. O., & Zhang, M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100221h · Cited by 128
Li, D., Ma, Y., Du, J., Tao, W., Du, X., Yang, X., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b05396 · Cited by 123
Self-citationTumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Xu, C., Zhang, H., Sun, C., Liu, Y., Shen, S., Yang, X., Zhu, Y., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.031 · Cited by 106
Self-citationChen, W., Achazi, K., Schade, B., & Haag, R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.012 · Cited by 102
Zhou, Q., Hou, Y., Zhang, L., Wang, J., Qiao, Y., Guo, S., Fan, L., Yang, T., Zhu, L., & Wu, H. (2017) · Theranostics · doi:10.7150/thno.18607 · Cited by 97
Self-citationActivable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery
Cheng, H. B., Zhu, J., Xu, X., Qiu, W., Lei, Q., Han, K., Cheng, Y., & Zhang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04517 · Cited by 96
A Multifunctional Envelope-type Nanodevice for Use in Nanomedicine: Concept and Applications
Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H., & Harashima, H. (2012) · Accounts of Chemical Research · doi:10.1021/ar200254s · Cited by 88
Liu, Z., Chen, X., Zhang, X., Gooding, J. J., & Zhou, Y. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600002 · Cited by 78
Synergism of Nanomaterials with Physical Stimuli for Biology and Medicine
Shin, T.-H., & Cheon, J. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00559 · Cited by 77
Cao, J., Su, T., Zhang, L., Liu, R., Wang, G., He, B., & Gu, Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.010 · Cited by 70
Comparison of pH-sensitive degradability of maleic acid amide derivatives
Kang, S., Kim, Y., Song, Y., Choi, J. U., Park, E., Choi, W., Park, J.-S., & Lee, Y. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.057 · Cited by 61
Li, J., Ke, W., Li, H., Zha, Z., Han, Y., & Ge, Z. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500379 · Cited by 59
Self-citationFan, M., Zeng, Y., Ruan, H., Zhang, Z., Gong, T., & Sun, X. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00377 · Cited by 24
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Gao, Y., Wang, J., Chai, M., Li, X., Deng, Y., Jin, Q., & Ji, J. (2020) · ACS Nano · doi:10.1021/acsnano.0c00269 · Cited by 305
Self-citationStimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J., Lin, Y., Lin, Z., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 292
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Zhou, Y., Chen, X., Cao, J., & Gao, H. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00649a · Cited by 213
Metadata
- Authors
- Du, J.-Z., Li, H.-J., & Wang, J.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-10-15
- Volume
- 51
- Issue
- 11
- Pages
- 2848-2856
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2897397780
- Cited by
- 276
- References
- 48
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.